Surgical site infection and antimicrobial use following caesarean section at QECH in Blantyre, Malawi: a prospective cohort study

Author:

Kachipedzu Amos Tumizani1,Kulapani David King2,Meja Samuel James3,Musaya Janelisa4

Affiliation:

1. Bwaila Hospital, P.O.Box 1274, Lilongwe

2. School of Life Sciences & Allied Health Professionals, Biomedical Sciences Department, Kamuzu University of Health Sciences, Private Bag 360, Chichiri, Blantyre

3. School of Medicine & Oral Health, Obstetrics and Gynaecology Department,Kamuzu University of Health Sciences, Private Bag 360, Chichiri, Blantyre

4. School of Global and Public Health, Kamuzu University of Health Sciences, Private Bag 360, Chichiri, Blantyre

Abstract

Abstract

Background: Surgical site infections (SSIs) are the third most common healthcare-associated infections (HAIs) and preventable complication of surgical procedure; continue to threaten public health with significant effects on the patients and health care human and financial resources. Therefore, this study aimed to determine the incidence of SSIs, risk factors and common microorganisms associated with SSI and assess the practice of antimicrobial use in women following CS at Queen Elizabeth Central Hospital (QECH). Methods: This was a hospital-based quantitative prospective study design involving pregnant women who underwent a Caesarean Section (CS) between February, 2023 and July, 2023 at QECH with 30 day-follow-ups. Some wound specimens (pus swabs) were collected from infected CS wounds and processed at QECH main laboratory, and susceptibility testing was conducted using the Kirby-Bauer disk diffusion method with results reported only as susceptible, intermediate, or resistant and the collected data was analyzed using Stata. Results: The overall cumulative incidence of SSI recorded at QECH during the study period was 10% (20 cases out of 208). Of these, 19 (95%) of them reported superficial SSI following CS. The mean age was 26.1 years with a standard deviation of 6.2. In contrast to the previous studies, potential risk factors including skin closure, age, parity or ANC visits were not associated with SSIs. The majority of patients with SSIs (n=12, 60%) were readmitted and 5 (25%) out of 20 with SSIs had antimicrobial resistance following susceptibility testing. Staphylococcus aureus was the most common organism (3, 60%) and other bacterial isolates included were Enterobacteriaceae and Acinetobacter baumanni. All pregnant women who underwent for CS received antibiotic prophylaxis. Conclusion: The incidence of SSIs and inappropriate antimicrobial use following CS remains a challenge at QECH. Therefore, due to increased number of SSIs following CS with relative emergence of AMR ensure intensive infection prevention and control practices, establishing AMS program and routine surveillance of SSIs at QECH.

Publisher

Research Square Platform LLC

Reference35 articles.

1. WHO guidelines to prevent surgical site infections;Solomkin J;Lancet Infect Dis,2017

2. Gibbons L, Belizán JM, Lauer JA, Betrán AP, Merialdi M, Althabe F. The global numbers and costs of additionally, needed and unnecessary caesarean sections performed per year: overuse as a barrier to universal coverage. Working Paper-World Health Report 2010. 2010. http://www.who.int/healthsystems/topics/financing/healthreport/30C-sectioncosts.pdf.

3. European Centre for Disease Prevention and Control. Surveillance of surgical site infections in Europe 2010–2011. Stockholm: ECDC; 2013.

4. Preventing infections acquired during healthcare delivery;Allegranzi B;Lancet,2008

5. Microbiological pattern of surgical site infection following caesarean section at the University of Calabar Teaching Hospital;Njoku CO;Maced J Med Sci,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3